enow.com Web Search

  1. Ads

    related to: wet macular degeneration eye drops

Search results

  1. Results from the WOW.Com Content Network
  2. Pegaptanib - Wikipedia

    en.wikipedia.org/wiki/Pegaptanib

    Pegaptanib [2] sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD). [3] It was discovered by NeXstar Pharmaceuticals (which merged with Gilead Sciences in 1999) and licensed in 2000 to EyeTech Pharmaceuticals, now OSI Pharmaceuticals, for late stage development and marketing in the United States.

  3. Ranibizumab - Wikipedia

    en.wikipedia.org/wiki/Ranibizumab

    Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment created from the same parent mouse antibody as bevacizumab.It is an anti-angiogenic [16] that is approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion.

  4. EyePoint Announces First Patient Dosed in Second Global Phase ...

    lite.aol.com/tech/story/0022/20241204/9313600.htm

    About Wet AMD. Wet age-related macular degeneration (wet AMD) is a leading cause of vision loss and irreversible blindness in people over the age of 50. Wet AMD is an advanced form of condition that develops when abnormal blood vessels grow into the macular retina, leaking blood or fluid, and leading to potentially severe vision loss.

  5. Macular degeneration - Wikipedia

    en.wikipedia.org/wiki/Macular_degeneration

    Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. [1] Early on there are often no symptoms. [1] Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. [1]

  6. EyePoint Pharmaceuticals Announces First Patient Dosed in ...

    lite.aol.com/tech/story/0022/20241024/9261009.htm

    WATERTOWN, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that the first patient has been dosed in the Phase 3 LUGANO clinical trial of DURAVYU ...

  7. How to reduce risks of macular degeneration - AOL

    www.aol.com/lifestyle/actress-judi-dench-says...

    Macular degeneration happens with age, when the macula, at the center of the retina — “the part of the eye that sees the world for us,” Dr. Vlad Diaconita, a retinal and vitreoretinal ...

  1. Ads

    related to: wet macular degeneration eye drops